Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jun;59(6):705-11.
doi: 10.1111/j.1365-2125.2005.02239.x.

Allometric relationships between the pharmacokinetics of propofol in rats, children and adults

Affiliations

Allometric relationships between the pharmacokinetics of propofol in rats, children and adults

Catherijne A J Knibbe et al. Br J Clin Pharmacol. 2005 Jun.

Abstract

Aims: Allometric equations have proven useful for the extrapolation of animal data to determine pharmacokinetic parameters in man. It has been proposed that these equations are also applicable over the human size range including the paediatric population. The aim of this work was to study the relationship between various pharmacokinetic parameters for propofol and body weight using data from rats, children and adults. Furthermore, the utility of allometric scaling is evaluated by the prediction of propofol concentrations in humans based on data obtained in the rat.

Methods: The relationship between the pharmacokinetic parameters of propofol obtained in rats, children and adults was analyzed by plotting the logarithmically transformed parameters against the corresponding logarithmically transformed body weights. In addition, based on allometric equations, pharmacokinetic parameters obtained in rats were scaled to humans. These parameters were used to simulate propofol concentrations in long-term sedated critically ill patients using NONMEM. Simulated concentrations were then compared with actually observed concentrations in humans.

Results: The relationship between pharmacokinetic parameters of propofol from rats, children and adults was in good agreement with those from the literature on allometric modelling. For clearance, intercompartmental clearance, central volume of distribution and peripheral volume of distribution, the power parameters were 0.78, 0.73, 0.98 and 1.1, respectively, and r2 values for the linear correlations were 0.990, 0.983, 0.977 and 0.994, respectively. On the basis of data obtained after a single bolus injection in the rat, adequate predictions of propofol concentrations in critically ill patients can be made using allometric equations, despite the long-term nature of the use of the drug, the large number of infusion changes per day and/or differences in state of health and age.

Conclusions: For propofol, allometric scaling has proved to be valuable for cross species extrapolation. Furthermore, the use of the allometric equation between adults and children seems to be an adequate tool for the development of rational dosing schemes for children of varying body weights, and requires further study.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clearance, intercompartmental clearance, volume of the central compartment and volume of the peripheral compartment of propofol vs body weight in rats following bolus injection [11], in children for sedation after a 6 h infusion following open-heart surgery [14] and in adults after a 5 h infusion for sedation following coronary artery bypass grafting [12]
Figure 2
Figure 2
Simulated concentrations using bolus injection data obtained in the rat (line) and observed propofol concentrations (dot) [13]vs time, in critically ill patients. Best, median and worst performances of individual simulations are presented

References

    1. Breimer DD, Danhof M. Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The ‘wooden shoe’ paradigm. Clin Pharmacokinet. 1997;32:259–67. - PubMed
    1. Danhof M. Pharmacokinetic/pharmacodynamic modelling: extrapolation from animals to humans. Eur J Pharm Sci. 1996;4(Suppl):S19–S20.
    1. Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, MacIntyre F, Rance DJ, Wastall P. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharmacol Exp Ther. 1997;283:46–58. - PubMed
    1. Lave T, Coassolo P, Reigner B. Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations. Clin Pharmacokinet. 1999;36:211–31. - PubMed
    1. Ings RM. Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica. 1990;20:1201–31. - PubMed

Publication types